Start typing to retrieve search suggestions. When suggestions are available use up and down arrows to review and ENTER to select. Continue typing to refine.
Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
Trusted Information Creator
Certified November 2025
{arrow_up} Back to top

Gilenya 0.5 mg hard capsules

Active Ingredient:
fingolimod hydrochloride
Company:  
Novartis Pharmaceuticals UK Ltd See contact details
ATC code: 
L04AE01
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials Letters to HCPs HCP Med Info
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

Gilenya (fingolimod) - Patients Information Booklet - for patients

Patients Information Booklet - for patients

{pdf_link}

Gilenya (fingolimod) - Pregnancy-Specific Patient Reminder Card - for patients

Pregnancy-Specific Patient Reminder Card - for patients

{pdf_link}

Gilenya (fingolimod) - Prescribers checklist - for Healthcare Professionals

{healthcare_pro_orange} For Healthcare Professionals

Prescribers checklist - for Healthcare Professionals

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Novartis Pharmaceuticals UK Ltd
Company image
Address
2nd Floor, The WestWorks Building, White City Place, 195 Wood Lane, London, W12 7FQ
Telephone
+44 (0)1276 692 255
Medical Information Direct Line
+44 (0)1276 698 370
Medical Information e-mail
[email protected]
Customer Care direct line
+44 (0)845 741 9442
E-mail
[email protected]